What does CUSIP 52187K101 represent in this 13F holders report?

CUSIP 52187K101 is the security identifier for LPTX - LEAP THERAPEUTICS INC - COM used to aggregate holder disclosures.

How many institutions held LPTX - LEAP THERAPEUTICS INC - COM in Q1 2023?

56 institutional investors reported LPTX - LEAP THERAPEUTICS INC - COM for Q1 2023. Use the holders table for investor-level position and value details.

LEAP THERAPEUTICS INC - COM (LPTX)

CUSIP: 52187K101

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / COM
Total 13F shares: 43,213,381
Total 13F value: $14,678,973
Share change: +10,256,759
Put/Call ratio: 21%
SEC-reported price per share: $0.34
Number of holders: 56
Value change: +$3,302,319
Number of buys: 23
Number of sells: 23

Security key

52187K101

Report period

Q1 2023

Institutions

Top holders

LPTX full security history Ownership snapshot Full 13F holder table CYPHERPUNK TECHNOLOGIES INC. SEC filings CYPHERPUNK TECHNOLOGIES INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of LPTX - LEAP THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BeOne Medicines Ltd.

Disclosed value leader

BeOne Medicines Ltd.

Comparable rows

0/15

Latest evidence

31 Dec 2022

3/4/5 13F Highest disclosed value: $20,943,045 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BeOne Medicines Ltd. has the largest disclosed position value at $20.94M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BeOne Medicines Ltd.'s linked filing trail.

Disclosed position value Top 5

BeOne Medicines Ltd. $20.94M

PERCEPTIVE ADVISORS LLC $3.03M

Artal Group S.A. $1.8M

Rock Springs Capital Management LP $1.65M

VANGUARD GROUP INC $1.44M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BeOne Medicines Ltd.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$20,943,045 7,348,437 shares	—	24 Sep 2021
PERCEPTIVE ADVISORS LLC	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	— denominator unverified	$3,026,923 6,726,496 shares	—	31 Dec 2022
Artal Group S.A.	13F Company 13F	— denominator unverified	$1,800,000 4,000,000 shares	—	31 Dec 2022
Rock Springs Capital Management LP	13F Company 13F	— denominator unverified	$1,646,931 3,659,847 shares	—	31 Dec 2022
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$1,444,861 3,210,802 shares	—	31 Dec 2022
683 Capital Management, LLC	13F Company 13F	— denominator unverified	$1,237,500 2,750,000 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

43,213,381

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %